Thrombospondin, a negative modulator of megakaryocytopoiesis

Journal of Laboratory and Clinical Medicine

Volumn 129, Issue 2, 1997, Pages 231-238

  Chen, Yuan Zhong ^b   Incardona, Francesca ^c   Legrand, Chantal ^c   Momeux, Laurence ^c   Caen, Jacques ^c   Han, Zhong Chao ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b Fujian Institute of Hematology   (China)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 12644314125     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(97)90144-X     Document Type: Article

References (37)

1. Frazier WA. Thrombospondins. Curr Opin Cell Biol 1991;3: 792-9.
2. Long MW, Briddell R, Water AW, Bruno E, Hoffman R. Human hematopoietic stem cell adherence to cytokines and matrix molecules. J Clin Invest 1992;90:251-5.
3. Iruela-Arispe ML, Bornstein P, Sage H. Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. Proc Natl Acad Sci USA 1990;88:5025-30.
4. Good DJ, Polverine PJ, Rastinejad F, Le Beau MM, Lemons RS, Frazier WA, et al. A tumor supressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci USA 1990;87:6624-8.
5. Taraboletti G, Roberts D, Liotta LA, Giavazzi R. Platelet thrombospondin modulates endothelial cell adhesion, motility and growth: a potential angiogenesis regulatory factor. J Cell Biol 1996;111:765-72.
6. Vogel T, Guo NH, Krutzsch HC, Blake DA, Hartman J, Mendelovitz S, et al. Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin-binding domain and synthetic peptides from the type 1 repeats of thrombospondin. J Cell Biochem 1993;53:74-84.
7. Dubernard V, Legrand C. Characterization of the binding of thrombospondin to human platelets and its association with the platelet cytoskeleton. J Lab Clin Med 1991;118:446-57.
8. Han ZC, Sensébe L, Abgrall JF, Brière J. Platelet factor 4 inhibits human megakaryocytopoiesis in vitro. Blood 1990;75: 1234-9.
9. Han ZC, Bellucci S, Tenza D, Caen JP. Negative regulation of megakaryocytopoiesis by human platelet factor 4 and β-thromboglobulin: comparative analysis in bone marrow cultures from normal individuals and patients with primary thrombocythaemia. Br J Haematol 1990;74:395-9.
10. Ishibashi T, Miller SL, Burstein SA. Type β transforming growth factor is a potent inhibitor of murine megakaryocytopoiesis in vitro. Blood 1987;69:1737-41.
11. Han ZC, Bellucci S, Wan HY, Caen JP. New insight into the regulation of megakaryocytopoiesis by haematopoietic and fibroblastic growth factors and transforming growth factor β1. Br J Haematol 1992;81:1-5.
12. Legrand C, Morandi V, Mendelovitz S, Shaked H, Hartman IR, Panet A. Selective inhibition of platelet macroaggregate formation by a recombinant heparin-binding domain of human thrombospondin. Arterioscler Thromb 1994;14:1784-91.
13. Han ZC. Identification of a murine high-proliferative-potential colony-forming cell (HPP-CFC) capable of producing a number of megakaryocytes and repleating for secondary HPP-CFCs in culture. J Lab Clin Med 1993;123:610-6.
14. Han ZC, Bikfalvi A, Shen ZX, Bodevin E. Recombinant human acidic fibroblast growth factor (aFGF) stimulates murine megakaryocyte colony formation in vitro. Int J Hematol 1992;55:281-6.
15. Bruno E, Briddle R, Hoffman R. Effect of recombinant and purified hematopoietic growth factors on human megakaryocyte colony formation. Exp Hematol 1988;16:371-85.
16. Messer HA, Jamal N, Izaguirre C. The growth of large megakaryocyte colonies from human bone marrow. J Cell Physiol 1982;(Suppl 1):45-51.
17. Wendling F, Maraskovsky E, Debili N, Florindo C, Teepe M, Titeux M, et al. C-Mpl ligand is a humoral regulator of megakaryocytopoiesis. Nature 1994;369:571-3.
18. Dixit VM, Grant GA, Santoro SA, Frazier WA. Isolation and characterization of a heparin-binding domain from the amino terminus of platelet thrombospondin. J Biol Chem 1984;259: 10100-5.
19. Lawler J, Weinstein R, Hynes RO. Cell attachment to thrombospondin: the role of Arg-Gly-Asp, calcium, and integrin receptors. J Cell Biol 1988:107:2151-61.
20. Takagi J, Fujisawa T, Usui T, Aoyama T, Saito Y. A signal chain 19-kDa fragment from bovine thrombospondin binds to type V collagen and heparin. J Biol Chem 1993;268: 15544-9.
21. Murphy-Ullrich JE, Gurusiddappa S, Frazier WA, Hook M. Heparin-binding peptides from thrombospondins 1 and 2 contain focal adhesion-labilizing activity. J Biol Chem 1993; 268:26784-9.
22. Yabkowitz R, Mansfield PJ, Ryan US, Suchard SJ. Thrombospondin mediates migration and potentiates platelet-derived growth factor-dependent migration of calf pulmonary smooth muscle cells. J Cell Physiol 1993;157:24-32.
23. Prater CA, Ploctkin J, Jaye D, Frazier WA. The properdin-like type repeats of human thrombospondin contain a cell attachment site. J Cell Biol 1991;112:1031-40.
24. Tolsma SS, Volpert OV, Good DJ, Frarier WA, Polverini PJ, Bouck N. Peptides derived from two seperate domains of the matrix protein thrombospondin 1 have anti-angiogenic activity. J Cell Biol 1993;122:497-511.
25. Guo N-H, Krutzsch HC, Négre E, Vogel T, Blake DA, Roberts DI. Heparin- and sulfatide-binding peptides from the type I repeats of human thrombospondin promote melanoma cell adhesion. Proc Natl Acad Sci USA 1992;89:3040-4.
26. Murphy-Ullrich JE, Schultz-Cherry S, Hoök M. Transforming growth factor-β complexes with thrombospondin. Mol Biol Cell 1992;3:181-8.
27. Schultz-Cherry S, Murphy-Ullrich JE. Thrombospondin causes activation of latent transforming growth factor-β secreted by endothelial cells by a novel mechanism. J Cell Biol 1993;122:923-32.
28. Bagavandoss P, Kaytes P, Vogeli G, Wells PA, Wieks JW. Recombinant truncated thrombospondin-1 monomer modulates endothelial cell plasminogen activator inhibitor 1 accumulation and proliferation in vitro. Biochem Biophys Res Commun 1993;192:325-32.
29. Sheibari N, Frariez WA. Thrombospondin 1 expression in transformed endothelial cells restores a normal phenotype and suppresses their tumorigenesis. Proc Natl Acad Sci USA 1995;92:6788-92.
30. Han ZC, Maurer AM, Bellucci S, Wan HY, Kroviarski Y, Bertrand O, et al. Inhibitory effect of platelet factor 4 (PF4) on the growth of human erythroleukemia cells: proposed mechanism of action of PF4. J Lab Clin Med 1992;120:645-60.
31. Maurer AM, Han ZC, Dirmier D, Brière J. Inhibitory effect of platelet factor 4 on the growth of human erythroleukemia cells is dependent on cell surface heparan sulfate. J Lab Clin Med 1996;127:382-90.
32. Shen ZX, Basara N, Xi XD, Caen JP, Maffrand JP, Pascal M, et al. Fraxiparin, a low-molecular-weight heparin, stimulates megakaryocytopoiesis in vitro and in vivo in mice. Br J Haematol 1994;88:608-12.
33. Han ZC, Bellucci S, Shen ZX, Maffrand JP, Pascal M, Petitou M, et al. Glycosaminoglycans enhance megakaryocytopoiesis by modifying the activities of hematopoietic growth factors. J Cell Physiol 1996;168:97-104.
34. Bikfalvi A, Han ZC, Fuhrmann G. Interaction of fibroblast growth factor (FGF) with megakaryocytopoiesis and demonstration of FGF receptor expression in megakaryocytes and megakaryocytic-like cells. Blood 1992;80:1905-13.
35. Klagsbrun M, Baird A. A dual receptor system is required for basic fibroblast growth factor activity. Cell 1991;67:229-31.
36. Cheifetz S, Massagué J. The TGF-β receptor proteoglycan: cell surface expression and ligand binding in the absence of glycosaminoglycan chains. J Biol Chem 1989; 264:12025-8.
37. Kaushansky K, Broudy VC, Lin N, Jorgensen MJ, McCarty P, Fox N, et al. Thrombopoietin, the Mpl ligand, is essential for full megakaryocyte development. Proc Natl Acad Sci USA 1995;92:3234-8.